
GEMS suspension puts governance under scrutiny
DENOSA says the lack of disclosure over Stan Moloabi’s suspension raises wider questions about the scheme’s leadership, accountability, and handling of member concerns.

DENOSA says the lack of disclosure over Stan Moloabi’s suspension raises wider questions about the scheme’s leadership, accountability, and handling of member concerns.

Discovery believes the legal challenges have shifted government’s thinking on NHI and created an opportunity to pursue a more workable path to universal health coverage.

The scheme says R1.7 billion in projected savings could moderate future increases as it prepares for robust talks with organised labour.

The regulator has rejected the scheme’s proposal to reduce its weighted average contribution adjustment to 7.5%, leaving the existing 9.5% increase in place.

New benefits, flexibility, and holistic well-being support strengthen Medihelp’s role as a healthcare partner, not just a funder.

Bestmed says that rand for rand its benefit options will remain competitive despite the proposed average increase of 12.75%.